openPR Logo
Press release

Inhaler Market Industry Size, Growth and Forecast to 2023

12-27-2019 11:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Inhaler Market Industry Size, Growth and Forecast to 2023

Inhaler Market Industry Size, Growth and Forecast to 2023

Global inhaler market is anticipated to grow at a CAGR of 2.7% during the forecast period. Rising level of air pollution is one of the major factors responsible for the increasing prevalence of lungs and cardiovascular diseases, which includes asthma and COPD. Urbanization is another prime contributor to asthma as it significantly increases the outdoor air pollution. According to World Health Organization (WHO), around nine out of every 10 people breathe polluted air, owing to which, nearly seven million mortalities occurs every year across the globe. This reflects the demand for inhalers for the treatment of asthma and COPD.

Request a free sample of our report on Inhaler Market: https://www.omrglobal.com/request-sample/inhaler-market

Moreover, increasing population base of smokers substantially increases the COPD patients, which in turn, spur the demand for inhalers in the global market. According to Institute of Health Metrics and Evaluation (IHME), in 2016, around 17 million fatalities occurred due to smoking in China. The rapidly growing attraction of youth towards smoking across the globe, which as a result motivating the market for inhalers in order to provide breathing solutions to the hugely affected population.

A full report of Global Inhaler Market is available at: https://www.omrglobal.com/industry-reports/inhaler-market

Significant prevalence of COPD has been recorded across the globe that is augmenting the demand for inhalers for its treatment. According to WHO, there were 251 million COPD cases were reported across the globe in 2016. Moreover, around 3.17 million mortalities were caused due to COPD in 2015, which is 5% of all the mortalities across the globe in 2016. The major cause of COPD is tobacco smoke and other factors such as occupational dusts and fumes as well as exposure to indoor or outdoor air pollution.

Some COPD cases occurs due to long-term asthma. It is expected to increase in future due to significant aging population and smoking prevalence across several countries. Over 90% of the mortalities occur in emerging economies. Moreover, according to WHO, 56.9 million mortalities were reported globally in 2016, of which more than half, that is 54% were occurred due to the top ten causes, including COPD, lower respiratory infections, and others.

Moreover, the increasing focus on the development of miniature and compact inhalers due to increasing penetration towards handy medical devices is providing a growth opportunity to the inhaler market. Healthcare providers have further started the development of smart inhalers, which supports Bluetooth technology, and works according to the health status of the patient. This, in turn, is anticipated to propel the global inhaler market in the near future. Some of the novel technologies introduced in the inhaler market is smart inhalers.

Current Market Trends Covered in the Global Inhaler Market Report

Based on the devices, the dry powder inhaler is estimated to hold a dominating market share during the forecast period.
Based on the application, asthma held the largest market share in the global inhaler market in 2018.
North America is estimated to dominate the global inhaler industry during the forecast period.

Global Inhaler Market Segmentation

By Device

Metered Dose Inhaler
Dry Powder Inhaler
Nebulizer
Nasal Inhaler

By Type

Preventive Inhaler
Reliever Inhaler
Long-acting bronchodilators

By Applications

Asthma
COPD

By End-User

Homecare
Hospitals and Clinics

Global Inhaler Market – Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/inhaler-market

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inhaler Market Industry Size, Growth and Forecast to 2023 here

News-ID: 1886473 • Views:

More Releases from Orion Market Research

Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forec …
Global healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Globally, a considerable increase in the burden of chronic diseases pressuring countries to adopt effective and efficient distribution of healthcare products. Commonly prevailing chronic diseases include heart attacks and strokes, cancer such as breast and colon, diabetes, epilepsy and seizures, obesity, and oral health issues. To learn more about this report request
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Prediabetes Market Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
Global prediabetes market is anticipated to grow at a CAGR of 7.2% during the forecast period (2024-2031). A major factor supporting the growth of the market is the increasing product expansion and new drugs in the market. For instance, in January 2024, Novo Nordisk announced the launch of its Wegovy, a GLP-1 analog in the UK. This drug can be prescribed to people with prediabetes and for weight loss purposes.
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
Rapid Test Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The global rapid test market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2024-2031). The increasing government initiatives for diagnosing infectious diseases owing to the growing prevalence of infectious diseases and the key developments by the market players. In order to monitor the infection rate of specific pathogens, infection monitoring and surveillance programs have grown over the past few several years. Rapid diagnostic
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
AI in Patient Engagement Market Size, Trends, Latest Insights, Analysis and Fore …
Global AI in patient engagement market is anticipated to grow at a CAGR of 21.0 % during the forecast period (2024-2031). AI-powered communication tools support patients by addressing their inquiries, scheduling appointments, and providing information about their health conditions and treatments. These tools enhance patient engagement, improve access to healthcare information, and streamline administrative processes for healthcare providers. Furthermore, AI algorithms analyze large datasets, including electronic health records (EHRs), medical

All 5 Releases


More Releases for Inhaler

Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Global Inhaler Market Research and Forecast 2018-2023
“Inhalers- a faster and better way to deliver respiratory medication” Orion Market Research (OMR) recently published a market research report on global inhaler market. It is forecasted that the market is augmenting with a significant CAGR during forecast period 2018-2023. The market is augmenting due to rising prevalence of respiratory disease, increasing air pollution and number of smokers. The global inhaler market is segmented by device, type, application and end-user. The
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
The Inhaler Devices has Driven The Market for Global Asthma Inhaler Device Marke …
Market Research Future published a Half - Cooked research report on “Global Asthma Inhaler Device Market Research Report- Forecast To 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd. and others are some of the prominent players at the forefront of competition in the Global Asthma Inhaler Devices Market and
Asthma Inhaler Device Market by Metered Dose, Spacer and Dry Powder Type Inhaler …
The Worldwide Asthma Inhaler Device Market report provides various factors- price analysis, supply chain analysis, porters five force analysis etc. The report provides key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market Browse Complete 90 Pages Report enabled with Respective Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market . Asthma is a type of inflammatory disease of the lungs. It